 |
Somatropin |
|---|---|
| Trade Name | Nutropin |
| Orphan Indication | For use in the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion |
| USA Market Approval | USA |
| USA Designation Date | 1987-03-06 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 |
